Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,026,224
  • Shares Outstanding, K 60,765
  • Annual Sales, $ 4,069 M
  • Annual Income, $ 560,120 K
  • EBIT $ 150 M
  • EBITDA $ 810 M
  • 60-Month Beta 0.26
  • Price/Sales 2.42
  • Price/Cash Flow 5.37
  • Price/Book 2.50

Options Overview Details

View History
  • Implied Volatility 38.60% (+0.89%)
  • Historical Volatility 29.43%
  • IV Percentile 50%
  • IV Rank 29.42%
  • IV High 69.53% on 08/05/25
  • IV Low 25.70% on 02/28/25
  • Expected Move (DTE 10) 7.78 (4.71%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 27
  • Volume Avg (30-Day) 324
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 10,461
  • Open Int (30-Day) 11,687
  • Expected Range 157.22 to 172.78

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 5.65
  • Number of Estimates 7
  • High Estimate 6.60
  • Low Estimate 5.09
  • Prior Year 5.70
  • Growth Rate Est. (year over year) -0.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
159.35 +3.54%
on 01/13/26
173.09 -4.67%
on 01/14/26
+3.87 (+2.40%)
since 01/09/26
3-Month
132.10 +24.91%
on 11/11/25
182.99 -9.83%
on 11/18/25
+33.84 (+25.80%)
since 11/07/25
52-Week
95.49 +72.79%
on 04/09/25
182.99 -9.83%
on 11/18/25
+44.71 (+37.17%)
since 02/07/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Jazz Pharmaceuticals is a specialty biopharmaceutical company with a focus in the areas of neuroscience & oncology. It derives the majority of its revenues from its sleep disorder drugs' Xywav & Xyrem. Both drugs are approved for treating cataplexy & excessive daytime sleepiness in narcolepsy patients....

See More

Key Turning Points

3rd Resistance Point 169.98
2nd Resistance Point 168.45
1st Resistance Point 166.73
Last Price 165.00
1st Support Level 163.47
2nd Support Level 161.94
3rd Support Level 160.21

See More

52-Week High 182.99
Last Price 165.00
Fibonacci 61.8% 149.57
Fibonacci 50% 139.24
Fibonacci 38.2% 128.91
52-Week Low 95.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar